Stay updated with breaking news from Path Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have been assigned an average recommendation of “Hold” from the fifteen research firms that are presently covering the firm, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]
Needham & Company LLC reiterated their buy rating on shares of UiPath (NYSE:PATH – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $20.00 price target on the healthcare company’s stock. Several other equities analysts have also commented on the stock. Barclays upped their price objective on shares […]
Glass Jacobson Investment Advisors llc acquired a new stake in shares of UiPath Inc. (NYSE:PATH – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 57,445 shares of the healthcare company’s stock, valued at approximately $952,000. Other large investors also recently bought […]
Royal Bank of Canada restated their sector perform rating on shares of UiPath (NYSE:PATH – Free Report) in a research note published on Thursday morning, Benzinga reports. Royal Bank of Canada currently has a $19.00 target price on the healthcare company’s stock. Several other equities analysts also recently weighed in on PATH. Macquarie lifted their […]
Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. Nine investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12-month target price […]